Response Biomedical FY 2012: net loss $5.3M

Key figures from this report

These are the numbers Response Biomedical reported for the year ended Dec 31, 2012, as tagged in the filing’s XBRL data, each against the year before. A plain-English reading of this report is not written yet.

1. Net income−$5.3MAgainst −$5.4M in FY 201110-K income statement, on EDGAR
2. Cash and cash equivalents$2.1M−72% from $7.4M in FY 201110-K balance sheet, on EDGAR
3. Cash from operations−$4.6MAgainst −$2.6M in FY 201110-K cash flow statement, on EDGAR